The firms will evaluate two adjuvant treatment options, Datroway with rilvegostomig or rilvegostomig monotherapy, against standard-of-care treatment.

Daiichi Sankyo promoted Hiroyuki Okuzawa to CEO, and he will take over from Sunao Manabe on April 1. Okuzawa is currently Daiichi’s chief operating officer.

AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...

He has covered insurance for a decade, including auto, home, life and health. Before cove... Ashlee is an insurance editor, journalist and business professional with an MBA and more than 17 years ...

AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate Enhertu is now approved to treat a new subset of breast cancer patients with very low levels of HER2 protein.

The National Testing Agency (NTA) has launched the e-certificates for candidates who qualified in the CSIR UGC NET June 2024 session. This is now a major incentive for those aspiring to hold positions ...

According to InvestingPro analysis, the company maintains a GREAT financial health score, positioning it well for ... However, AstraZeneca and its partner Daiichi Sankyo withdrew their application for ...

According to InvestingPro analysis, the company maintains a GREAT financial health score ... However, AstraZeneca and its partner Daiichi Sankyo withdrew their application for marketing ...

1 Day DSKYF 10.11% DJIA 1.65% S&P 500 1.83% Health Care/Life Sciences 0.69% ...

Upon completion of the program, graduates are prepared to be recognized as advanced practice nurses by the California State Board of Registered Nursing and eligible to take the Family Psychiatric ...

VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company ...